ECIL recommendations for the use of biological markers for the diagnosis of invasive fungal diseases in leukemic patients and hematopoietic SCT recipients, Bone Marrow Transplantation, vol.48, issue.6, pp.846-854, 2011. ,
DOI : 10.1038/bmt.2011.178
Prospective Evaluation of Clinical and Biological Markers To Predict the Outcome of Invasive Pulmonary Aspergillosis in Hematological Patients, Journal of Clinical Microbiology, vol.50, issue.3, pp.823-830, 2012. ,
DOI : 10.1128/JCM.00750-11
URL : https://hal.archives-ouvertes.fr/hal-00818504
Early Serum Galactomannan Trend as a Predictor of Outcome of Invasive Aspergillosis, Journal of Clinical Microbiology, vol.50, issue.7, pp.2330-2336, 2012. ,
DOI : 10.1128/JCM.06513-11
Rat monoclonal antibodies against Aspergillus galactomannan, Infect Immun, vol.60, pp.2237-2245, 1992. ,
Comparison of an enzyme immunoassay and latex agglutination test for detection of galactomannan in the diagnosis of invasive aspergillosis, European Journal of Clinical Microbiology & Infectious Diseases, vol.62, issue.2, pp.139-145, 1996. ,
DOI : 10.1007/BF01591487
Serum Aspergillus galactomannan antigen testing by sandwich ELISA: Practical use in neutropenic patients, Journal of Infection, vol.35, issue.1, pp.7-15, 1997. ,
DOI : 10.1016/S0163-4453(97)90833-1
Screening for circulating galactomannan as a noninvasive diagnostic tool for invasive aspergillosis in prolonged neutropenic patients and stem cell transplantation recipients: a prospective validation, Blood, vol.97, issue.6, pp.1604-1610, 2001. ,
DOI : 10.1182/blood.V97.6.1604
Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group, Clinical Infectious Diseases, vol.46, issue.12, pp.1813-1821, 2008. ,
DOI : 10.1086/588660
Epidemiological trends in invasive aspergillosis in France: the SAIF network (2005???2007), Clinical Microbiology and Infection, vol.17, issue.12, pp.1882-1889, 2005. ,
DOI : 10.1111/j.1469-0691.2011.03548.x
URL : https://hal.archives-ouvertes.fr/hal-00680990
Detection of circulating galactomannan for the diagnosis and management of invasive aspergillosis, The Lancet Infectious Diseases, vol.4, issue.6, pp.349-357, 2004. ,
DOI : 10.1016/S1473-3099(04)01045-X
Diagnosis of Invasive Aspergillosis Using a Galactomannan Assay: A Meta-Analysis, Clinical Infectious Diseases, vol.42, issue.10, pp.1417-1427, 2006. ,
DOI : 10.1086/503427
galactomannan antigen, Transplant Infectious Disease, vol.14, issue.1, pp.218-219, 2012. ,
DOI : 10.1111/j.1399-3062.2011.00707.x
Instability of Aspergillus Galactomannan in Stored Clinical Samples, Journal of Clinical Microbiology, vol.52, issue.12, 2014. ,
DOI : 10.1128/JCM.01912-14
Galactomannan: testing the same sample twice?, Transplant Infectious Disease, vol.46, issue.12, pp.38-39, 2012. ,
DOI : 10.1111/j.1399-3062.2012.00733.x
Significant Decline in Galactomannan Signal during Storage of Clinical Serum Samples, International Journal of Molecular Sciences, vol.14, issue.7, pp.12970-12977, 2013. ,
DOI : 10.3390/ijms140712970
The effect of sample storage on the performance and reproducibility of the galactomannan EIA test, Medical Mycology, vol.52, issue.6, pp.618-626, 2014. ,
DOI : 10.1093/mmy/myu014
Lack of intra-laboratory reproducibility in using Platelia Aspergillus enzyme immunoassay test for detection of Aspergillus galactomannan antigen, Transplant Infectious Disease, vol.28, issue.(6), pp.107-109, 2012. ,
DOI : 10.1111/j.1399-3062.2011.00663.x
Reproducibility of Positive Results for the Detection of Serum Galactomannan by Platelia??? Aspergillus EIA, Mycopathologia, vol.4, issue.6, pp.295-297, 2013. ,
DOI : 10.1007/s11046-013-9670-z
Reproducibility of Low Galactomannan Enzyme Immunoassay Index Values Tested in Multiple Laboratories, Journal of Clinical Microbiology, vol.43, issue.9, pp.4796-4800, 2005. ,
DOI : 10.1128/JCM.43.9.4796-4800.2005
Long-Term Stability at -20??C of Aspergillus Galactomannan in Serum and Bronchoalveolar Lavage Specimens, Journal of Clinical Microbiology, vol.52, issue.6, pp.2108-2111, 2014. ,
DOI : 10.1128/JCM.03500-13
Insufficient Demonstration of Long-Term Stability of Aspergillus Galactomannan, Journal of Clinical Microbiology, vol.52, issue.11, p.25324240, 2014. ,
DOI : 10.1128/JCM.02342-14
Reply to "Insufficient Demonstration of Long-Term Stability of Aspergillus Galactomannan", Journal of Clinical Microbiology, vol.52, issue.11, p.25324241, 2014. ,
DOI : 10.1128/JCM.02433-14
Piperacillin/tazobactam (TazocinTM) seems to be no longer responsible for false-positive results of the galactomannan assay, Journal of Antimicrobial Chemotherapy, vol.67, issue.7, pp.1746-1748, 2012. ,
DOI : 10.1093/jac/dks111
Laboratory diagnosis of invasive aspergillosis: from diagnosis to prediction of outcome . Scientifica (Cairo) 2013: 459405. doi: 10, pp.459405-24278780, 1155. ,
False Positive Galactomannan Test after Ice-Pop Ingestion, New England Journal of Medicine, vol.369, issue.1, pp.97-98, 2013. ,
DOI : 10.1056/NEJMc1210430